Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?

Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?

Abstract Anticoagulation therapy is a critical component of post-transcatheter aortic valve implantation (TAVI) management, aimed at reducing the risk of thromboembolic events and mortality. This review examines the efficacy of continuous versus interrupted anticoagulation strategies in TAVI patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Ravi Patel, Emmanuel Kokori, Gbolahan Olatunji, Israel Charles Abraham, Adeola Akinboade, Emmanuel Ababio Agyemang, Adetola Babalola, Nicholas Aderinto
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Thrombosis Journal
Subjects:
Anticoagulation
Transcatheter Aortic Valve Implantation (TAVI)
Direct Oral Anticoagulants (DOACs)
Thromboembolic Events
Online Access:https://doi.org/10.1186/s12959-025-00686-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12959-025-00686-z

Similar Items